Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) being developed for treating inflammatory diseases. It inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.
Molecular Weight:
443.5
Purity:
99.42%
CAS Number:
[1800046-95-0]
Formula:
C23H25N9O
Target:
Syk
T11824LL
* VAT and and shipping costs not included. Errors and price changes excepted